𝔖 Bobbio Scriptorium

✦ LIBER ✦

Efalizumab for severe palmo-plantar psoriasis: an open-label pilot trial in five patients

✍ Scribed by AMG Brunasso; C Salvini; C Massone

Book ID: 111095829
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 128 KB
Volume: 23
Category: Article
ISSN: 0926-9959
DOI: 10.1111/j.1468-3083.2008.03062.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab for severe palmoplantar psori

Adalimumab for severe palmoplantar psoriasis: An open-label pilot trial in nine patients

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Safety and tolerability of efalizumab th

Safety and tolerability of efalizumab therapy for patients with moderate to severe chronic plaque psoriasis: Results of an open-label phase IIIb multicenter trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Clinical effectiveness and safety experi

Clinical effectiveness and safety experience with efalizumab in the treatment of patients with moderate-to-severe plaque psoriasis in Taiwan: results of an open-label, single-arm pilot study

✍ TF Tsai; MT Liu; YH Liao; D Licu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

An investigator-initiated, open-label st

An investigator-initiated, open-label study evaluating the efficacy and safety of ustekinumab in patients with moderate to severe palmar plantar psoriasis

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Efficacy of efalizumab for the treatment

Efficacy of efalizumab for the treatment of moderate to severe plaque psoriasis: A prospective, 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Safety of efalizumab for the treatment o

Safety of efalizumab for the treatment of moderate to severe plaque psoriasis: A prospective 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB